Transplant, Cellular, and Experimental Therapeutics
The Transplant, Cellular, and Experimental Therapeutics (TCET) program serves as the primary translational engine of the Masonic Cancer Center, centralizing product development, manufacturing, and early-phase clinical trials. The program acts as a vital bridge, transitioning prioritized discoveries from across the research enterprise into clinical applications. By uniting expertise in transplantation, medicinal chemistry, and cell therapy, TCET accelerates the movement of laboratory innovations to the patient's bedside.
